The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy
Gennaro Giustino1,2, MD; Robert M.A. Van der Boon3, MD, PhD; Javier Molina-Martin de Nicolas4, MD; Nicolas Dumonteil5, MD; Alaide Chieffo1, MD; Peter P.T. de Jaegere3, MD, PhD; Didier Tchetche4, MD; Bertrand Marcheix5, MD, PhD; Damien Millischer4, MD; Romain Cassagneau4, MD; Didier Carrié5, MD, PhD; Nicolas M. Van Mieghem3, MD, PhD; Antonio Colombo1*, MD
1. Department of Cardio-Thoracic and Vascular Diseases, San Raffaele Scientific Institute, Milan, Italy; 2. The Icahn School of Medicine at Mount Sinai Cardiovascular Institute, New York, NY, USA; 3. Department of Interventional Cardiology, Thoraxcenter, E
Aims: We sought to evaluate the impact of permanent pacemaker (PPM) implantation on two-year mortality and one-year left ventricular ejection fraction recovery (∆LVEFR=one-year LVEF–basel